De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
CNC Overzicht aandelen
Centene Corporation is een gezondheidszorgonderneming die programma's en diensten levert aan onderverzekerde en onverzekerde gezinnen, commerciële organisaties en militaire gezinnen in de Verenigde Staten.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 5/6 |
| Toekomstige groei | 1/6 |
| Prestaties in het verleden | 2/6 |
| Financiële gezondheid | 4/6 |
| Dividenden | 0/6 |
Beloningen
Risicoanalyse
Geen risico's gedetecteerd voor CNC uit onze risicocontroles.
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Navigating Healthcare's Dynamic Landscape To Expand Margins And Secure Profitable Growth
Centene Corporation Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$72.08 |
| 52 Week Hoogtepunt | US$81.42 |
| 52 Week Laag | US$63.45 |
| Bèta | 0.48 |
| 11 maand verandering | 1.76% |
| 3 maanden verandering | 8.90% |
| 1 Jaar Verandering | 2.66% |
| 33 jaar verandering | 12.05% |
| 5 jaar verandering | 62.82% |
| Verandering sinds IPO | 4,928.83% |
Recent nieuws en updates
Should You Be Adding Centene (NYSE:CNC) To Your Watchlist Today?
Sep 26
Centene (NYSE:CNC) Has Some Way To Go To Become A Multi-Bagger
Sep 08Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly
Aug 20Centene Corporation: Strategic Market Position Amid Favorable Trends, Buy
Aug 20Recent updates
Should You Be Adding Centene (NYSE:CNC) To Your Watchlist Today?
Sep 26Centene (NYSE:CNC) Has Some Way To Go To Become A Multi-Bagger
Sep 08Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly
Aug 20Centene Corporation: Strategic Market Position Amid Favorable Trends, Buy
Aug 20Centene (NYSE:CNC) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Aug 02Here's Why We Think Centene (NYSE:CNC) Is Well Worth Watching
Jun 22A Piece Of The Puzzle Missing From Centene Corporation's (NYSE:CNC) Share Price
Jun 04Returns At Centene (NYSE:CNC) Appear To Be Weighed Down
May 14These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well
Apr 26Centene Corporation Still An Opportunity With An A-Grade Valuation
Mar 31If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity
Mar 15Market Still Lacking Some Conviction On Centene Corporation (NYSE:CNC)
Feb 08Centene: Stay Defensive Amid Economic Uncertainty With This Low-Beta Bargain
Jan 22Is Centene (NYSE:CNC) Using Too Much Debt?
Jan 21Centene: Overlooked Healthcare Giant
Nov 21Does Centene (NYSE:CNC) Deserve A Spot On Your Watchlist?
Nov 10Centene: Solid Performance With Positive Outlook, But Limited Upside Potential
Oct 26These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well
Oct 22Decoding Centene: Why I Think It's Undervalued
Oct 10If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity
Jul 31Centene: Results Impress But Buyers Aren't Swarming Yet
Jul 27Centene (NYSE:CNC) Has A Pretty Healthy Balance Sheet
Jul 12Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly
Apr 10Centene Non-GAAP EPS of $0.86 beats by $0.02, revenue of $35.56B beats by $190M
Feb 07With EPS Growth And More, Centene (NYSE:CNC) Makes An Interesting Case
Jan 27Centene (NYSE:CNC) Seems To Use Debt Rather Sparingly
Dec 27Centene: Once Again, With Quality, Now A 'Buy'
Dec 23Centene appoints new leadership; Ken Fasola President of Centene, Dave Thomas CEO of Medicaid
Dec 14An Intrinsic Calculation For Centene Corporation (NYSE:CNC) Suggests It's 50% Undervalued
Nov 11Is Now The Time To Put Centene (NYSE:CNC) On Your Watchlist?
Oct 26Centene Q3 2022 Earnings Preview
Oct 24Centene: Future Growth Will Exceed Market Expectations
Oct 14Centene: A Chaos Stock
Sep 28Rendement voor aandeelhouders
| CNC | US Healthcare | US Markt | |
|---|---|---|---|
| 7D | -3.4% | -1.2% | 0.4% |
| 1Y | 2.7% | 8.2% | 32.6% |
Rendement versus industrie: CNC presteerde slechter dan de US Healthcare -sector, die het afgelopen jaar een rendement van 10.8 % opleverde.
Rendement versus markt: CNC presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 34.1 % opleverde.
Prijsvolatiliteit
| CNC volatility | |
|---|---|
| CNC Average Weekly Movement | 4.8% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiele aandelenkoers: CNC heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 5% ) van CNC is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1984 | 67,700 | Sarah London | www.centene.com |
Centene Corporation is een onderneming in de gezondheidszorg die programma's en diensten biedt aan onderverzekerde en onverzekerde gezinnen, commerciële organisaties en militaire gezinnen in de Verenigde Staten. Het bedrijf is actief in de segmenten Medicaid, Medicare, Commercial en Other. Het segment Medicaid biedt dekking via gezondheidsplannen, waaronder medicaid-uitbreiding, ouderen-, blinden- en gehandicaptenzorg, kinderzorgverzekeringsprogramma, pleegzorg, medicare-medicaid plannen, langetermijndiensten en ondersteuning.
Centene Corporation Samenvatting
| CNC fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$37.92b |
| Inkomsten(TTM) | US$2.82b |
| Inkomsten(TTM) | US$144.06b |
13.4x
Koers/Winstverhouding0.3x
P/S-verhoudingIs CNC overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| CNC resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$144.06b |
| Kosten van inkomsten | US$121.81b |
| Brutowinst | US$22.25b |
| Overige uitgaven | US$19.43b |
| Inkomsten | US$2.82b |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
Oct 25, 2024
| Winst per aandeel (EPS) | 5.37 |
| Brutomarge | 15.45% |
| Nettowinstmarge | 1.96% |
| Schuld/Eigen Vermogen Verhouding | 64.2% |
Hoe presteerde CNC op de lange termijn?
Bekijk historische prestaties en vergelijking